El Guapo Pasilla-Ancho Chile Pods 2oz, 7.5oz, 11oz
⚠ Critical Alert — Stop Using Immediately
This product has been flagged with severe risks (undeclared allergen). Stop using it now and contact the brand or FDA for a refund, repair, or replacement.
FDA Recall Notice
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1346-2019.
Mojave Foods Corporation (subsidiary of McCormick) is initiating a voluntary recall of El Guapo Chile Habanero and Chile Pasilla-Ancho pouches due to unlabeled peanut allergen.
Corrective Action (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1346-2019.
Recall terminated by FDA.
✅ What you should do
- Stop using the product if you own it.
- Check the model number, lot code, or sell-by date against the recall notice above.
- Contact Mccormick & Company, Inc. - Flavor Manufacturing Center or the retailer where you bought it for a refund, replacement, or repair.
- For the most current official instructions, visit the FDA recall page.
- If you've been hurt by this product, report the incident to FDA.
Consumer Contact (per FDA)
Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1346-2019.
McCormick & Company, Inc. - Flavor Manufacturing Center
About the U.S. Food and Drug Administration
The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.
Visit FDA.gov →📣 Report a food, supplement, or cosmetic problem to the FDA
If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.
Mccormick & Company, Inc. - Flavor Manufacturing Center Recall FAQ
Mccormick & Company, Inc. - Flavor Manufacturing Center is the subject of a food safety report: El Guapo Pasilla-Ancho Chile Pods 2oz, 7.5oz, 11oz. The notice was published on January 11, 2019 by the U.S. Food and Drug Administration (FDA). Approximately 2 units are potentially affected.